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Cell plasticity or potency is necessary for the forma-
tion of multiple cell types. The mechanisms underly-
ing this plasticity are largely unknown. Preimplanta-
tion mouse embryos undergo drastic changes in
cellular potency, starting with the totipotent zygote
through to the formation of the pluripotent inner cell
mass (ICM) and differentiated trophectoderm in the
blastocyst. Here, we set out to identify and function-
ally characterize chromatin modifiers that define the
transitions of potency and cell fate in the mouse
embryo. Using a quantitative microfluidics approach
in single cells, we show that developmental transi-
tions are marked by distinctive combinatorial profiles
of epigenetic modifiers. Pluripotent cells of the ICM
are distinct from their differentiated trophectoderm
counterparts. We show that PRDM14 is heteroge-
neously expressed in 4-cell-stage embryos. Forced
expression of PRDM14 at the 2-cell stage leads to
increased H3R26me2 and can induce a pluripotent
ICM fate. Our results shed light on the epigenetic net-
works thatgoverncellularpotencyand identity invivo.
INTRODUCTION
Cell plasticity is essential for the formation of pluripotent cells
and the development of multicellular organisms. However, the
molecular mechanisms underlying cell plasticity are largely
unknown.CeThe mammalian embryo undergoes major changes in cell
plasticity before implantation, resulting in the generation of cells
of different potencies. The tight regulation of such transitions in
potency is essential to ensure the formation of the new organism.
In mammals, development begins with the formation of the
zygote following fusion of the gametes. Epigenetic reprogram-
ming of the gametes after fertilization is necessary to restore
full developmental plasticity in the newly formed embryo. The
zygote is therefore a totipotent cell because it is able to produce
all cell types in a new organism, including embryonic and extra-
embryonic tissues. Subsequent development is accompanied
by a progressive narrowing of developmental potency and pro-
ceeds to the first lineage choice: the separation of the pluripotent
inner cell mass (ICM) and the outer, more differentiated trophec-
toderm (TE) in the blastocyst. Thus, during the first 3 days of
development, the mouse embryo comprises totipotent, pluripo-
tent, and differentiated cells. The preimplantationmouse embryo
provides a unique model for exploring the foundations of totipo-
tency and differentiation in vivo.
Although lineage allocation between ICM and TE is only
morphologically visible at the blastocyst stage, the first cell-dif-
ferentiation event can be appreciated earlier, at the 8-cell
stage, when individual blastomeres become polarized (Ziomek
and Johnson, 1980). A number of subsequent asymmetric cell
divisions from the 8- to 32-cell stage lead to the formation of
distinct inner apolar and outer polar cells in the 16-cell morula
and 32-cell-stage early blastocyst. The inside/outside position
of the resulting cells correlates with subsequent lineage alloca-
tion to the ICM or TE, respectively, in the blastocyst (Johnson
and McConnell, 2004). The TE is a functional epithelium
that gives rise to extraembryonic tissues required for implanta-
tion, whereas the ICM cells retain their pluripotent character
and subsequently form the primitive endoderm (PE) and thell Reports 5, 687–701, November 14, 2013 ª2013 The Authors 687
epiblast (EPI), which gives rise to all cells of the developing
embryo itself.
How the transitions in potency are regulated at the molecular
level remains a crucial and poorly understood question in devel-
opmental and stemcell biology. A number of transcription factors
(TFs) have been identified as critical for themaintenance of these
lineages, includingCdx2 for the TE, andNanog and Pou5f1/Oct4
for the ICM. However, Nanog and Oct4 are not required for the
initial lineage establishment to occur (Mitsui et al., 2003; Nichols
et al., 1998). TE commitment occurs initially at the 32-cell stage,
and concordantly Cdx2 expression becomes restricted to outer
cells at this point (Dietrich and Hiiragi, 2007; Strumpf et al.,
2005). ICM commitment seems to occur later than TE commit-
ment, during the 32- to 64-cell stages, although the core TFs
associated with the identity of inner cells, Nanog and Oct4, un-
dergo complete lineage restriction only one to two cell cycles
later (Dietrich and Hiiragi, 2007; Guo et al., 2010). A recent study
that analyzed the expression of TFs expressed at the single-cell
level in early mouse embryos suggested that there is a gradient
of expression among blastomeres of some TFs (e.g., Sox2) in
the 16-cell morula stage (Guo et al., 2010).
The chromatin state of the TE and ICM lineages is expected to
be crucial for their initial commitment and differentiation poten-
tial. Chromatin modifier complexes likely act to generate a chro-
matin environment that allows lineage-specific TFs to exercise
their functions in cell-fate decisions. Furthermore, they also
have the potential to transmit molecular changes across cell
divisions. Notably, the epigenetic dynamics during mamma-
lian preimplantation development are characterized by major
changes in DNA methylation, histone modifications, and the
incorporation of histone variants (Burton and Torres-Padilla,
2010; Hemberger et al., 2009). Other investigators (Parfitt and
Zernicka-Goetz, 2010) and we (Torres-Padilla et al., 2007) have
shown that the first differentiation events in the embryo can be
orchestrated by histone modifications. In particular, we showed
that methylation of arginine 26 in histone H3 (H3R26me2) by the
protein arginine methyl transferase 4 (PRMT4/CARM1) can regu-
late cell fate. Collectively, these findings suggest that chromatin
modifications and their modifiers play a crucial, but still poorly
understood, role in the processes of reprogramming and differ-
entiation during development.
Lineage-tracing approaches and micromanipulation of indi-
vidual blastomeres have led to the general consensus that the
fates of individual blastomeres are not fully determined until
the blastocyst forms, implying that although two distinct lineages
emerge at the 16-cell stage, embryonic cells retain plasticity and
are not committed until the subsequent division occurs (Guo
et al., 2010; Johnson, 2009). Therefore, single-cell gene-expres-
sion analysis of blastomeres during this transition can reveal
previously unidentified patterns in the molecular composition
of individual blastomeres, which may provide the foundations
for cellular potency and lineage segregation.
In order to obtain insights into the epigenetic mechanisms
behind cell potency and lineage segregation in the mouse
embryo, we conducted simultaneous quantitative and combina-
torial expression profiling of chromatin modifiers in single cells
throughout preimplantation development using microfluidics
technology. We show that developmental transitions are marked688 Cell Reports 5, 687–701, November 14, 2013 ª2013 The Authorsby distinctive combinatorial profiles of epigenetic modifiers. Our
data reveal an unexpected and robust definition of cellular states
by a cohort of epigeneticmodifiers.Moreover,wedetermined the
quantitative enrichment of specific chromatin modifiers in the
ICMand askedwhether they can be predictive of ICMdetermina-
tion. We find that one such modifier, Prdm14, shows a hetero-
geneous expression pattern in 4-cell-stage embryos and is
subsequently highly enriched in ICM cells of the blastocyst. We
show that expressionofPrdm14at the2-cell stagedrives cells to-
ward the pluripotent ICM. PRDM14 interacts with CARM1 and
expression of Prdm14 promotes H3R26me2. Our data under-
score an instructive role for PRDM14 in regulating cell fate during
early mammalian embryogenesis and suggest a model whereby
PRDM14 and CARM1 function to promote pluripotency in vivo.
RESULTS
We performed a quantitative analysis of expression patterns
in single cells using the Fluidigm Biomark System with 48:48
Dynamic Array chips coupled to TaqMan gene-expression as-
says. Single blastomeres were prepared by manual disaggrega-
tion of mouse embryos harvested at the required time points. We
analyzed all embryo stages, from germinal-vesicle-stage oocyte
to early blastocyst (3.5 days postfertilization), and included indi-
vidual cells from both TE and ICM lineages. We analyzed the
expression patterns of 39 genes and two internal controls
(Table S1 available online). We focused our analysis primarily
on enzymes that are involved in establishing or removing various
histone lysine or arginine methylation marks. In addition, we
included the DNA methyltransferases Dnmt1, Dnmt3a, Dnmt3b,
and Dnmt3l, and four TFs that serve as ICM (Nanog and Oct4/
Pou5f1) or TE (Cdx2 and Id2) markers. This enabled us to corre-
late the expression patterns of chromatin modifiers to ICM and
TE lineages and to validate the robustness of our data against
that of a previous study that characterized expression of TFs in
the mouse embryo (Guo et al., 2010; Figure S2). The absolute
(unnormalized) levels of expression of all genes at all stages
analyzed are shown in Figure S1. We validated a set of nine
genes in single cells of the zygote and up to the 4-cell stage using
quantitative RT-PCR (qRT-PCR), and at the protein level when
antibodies were available (see below). Importantly, all genes
analyzed behaved as predicted by the Biomark data in terms
of both their average expression levels and their biological vari-
ability between individual cells of a particular stage (Figure S3).
Developmental Transitions Are Defined by Distinctive
Combinatorial Profiles of Epigenetic Modifiers
We first addressed whether different developmental stages and
degrees of cell potency can be defined on the basis of epigenetic
components. For this purpose, we first performed unsupervised
hierarchical clustering of all blastomeres and all genes (Fig-
ure 1A), which revealed that cells cluster primarily according to
their developmental stage of origin, up to and including the
majority of 8-cell-stage cells (Figure 1A). Thus, developmental
phases can be defined by the expression of a cohort of
chromatin modifiers. The oocyte, zygote, and 2-cell-stage
blastomeres are clearly distinguished from the later stages of
development, and therefore the maternal-to-zygotic transition
delineates the strongest difference in the clustering analysis.
These earlier stages show strong expression of most of the chro-
matinmodifiers analyzed,most likely reflecting the abundance of
maternal transcripts present in oocytes and zygotes and, to a
lesser extent, 2-cell-stage embryos (Hamatani et al., 2004). Inter-
estingly, however, the oocyte and zygote do not express all
genes and may also be characterized by the common absence
or low expression of a number of genes, including Suv39h1,
Kdm4c, andKdm5b, whereas theDnmt1 transcript is specifically
lost in zygotes. This is consistent with previous reports docu-
menting loss of Dnmt1 in zygotes while a differentially spliced
isoform Dnmt1o is expressed (Ratnam et al., 2002). Note that
the cells from the two lineages of the blastocyst, the ICM (E32I)
and TE (E32O), cluster less well based on the chromatin modi-
fiers they express compared with the TFs they express (compare
Figures 1A and S2). Interestingly, ICM cells are more variable
among themselves (Figure 1A, orange). This feature may reflect
more flexibility or heterogeneity in ICM cells than in TE cells
(see below).
Chromatin modifiers of similar activity do not seem to be cor-
egulated, with a few exceptions. For example, the Dnmt3a,
Dnmt3b de novo DNA methyltransferases and Dnmt3l, the non-
catalytic DNA methyltransferase 3-like protein, all cluster in a
group, suggesting that the de novo DNA methyltransferases
share a common regulation across preimplantation develop-
ment. This is probably required for the establishment of de
novo DNA methylation patterns (Borgel et al., 2010; Okano
et al., 1999). In addition, two histone H3K4 demethylases,
Kdm5a and Kdm5b (formerly Jarid1a and Jarid1b), also consis-
tently cluster together. Finally, the two PR-domain-containing
proteins analyzed, PRDM14 and PRDM15 (of thus-far-unknown
biochemical function) also cluster together, potentially reflecting
similar or overlapping roles during early embryogenesis. Impor-
tantly, our data also uncovered variability in the gene-expression
profiles of individual cells. For example, the Polycomb subunit
Ring1a reproducibly shows high variability between cells at
each stage (Figures 1A and S1).
Second, to investigate predominant gene-expression pat-
terns, we applied principal component analysis (PCA) to our
data set. This form of mathematical analysis identifies compo-
nents of large gene-expression data sets that are able to reduce
as much of the variance in the data set as possible into single
dimensions, depicted on axes of a graph, highlighting similarities
and differences within the data set. For the PCA shown in Fig-
ure 1B, the data points are the single cells taken from all stages
of preimplantation development and the variables are the 39-
dimensional gene set, normalized to the control genes. Each
component in the PCA retains contributions from all the genes
in the data set, and the relative contributions (weights) of the
genes to each principal component are shown in Figure 1C,
with genes with a more positive PC score enriched in cells with
a more positive corresponding PC score. In the PCA of our
gene-expression data set, the first component is represented
on the x axis and explains 56% of the total variance in the data
set. The second, uncorrelated component explains 5.6% of the
remaining variance on the y axis.
The PCA reveals a striking distribution of all blastomeres ac-
cording to their developmental origin, indicating that each devel-Ceopmental stage is characterized quantitatively and qualitatively
by a precise combination of chromatin modifiers (Figure 1B).
The first principal component (PC1, x axis) separates the cells
into developmental stages ranging from oocyte to the 8-cell
stage, indicating that the expression patterns of the chromatin
modifiers differ sufficiently between stages to allow their segre-
gation. The most significant variation in the data set is due to
differences between early and later stages of development,
with the 8-cell stage marking this transition (Figure 1B). Thus,
this component does not simply reflect the maternal–zygotic
transition, which is largely completed at the 2-cell stage. In
contrast, from the 8-cell stage to the blastocyst stage, cells are
no longer separated by PC1, but by PC2 on the y axis. The
ICM (E32I) and TE (E32O) cells of the blastocyst are clearly
distinct (defined in PC2), suggesting that the secondmost impor-
tant variation in the data set is the segregation of the two lineages
of the blastocyst. Only the 16-cell-stage blastomeres do not
cluster into a developmental stage in the PCA, as they are spread
between the positions of the ICM and TE cells of the blastocyst.
This is likely to represent a gradient of chromatin modifier
expression in the 16-cell-stage cells that reflects ICM and TE
fates emerging from the subsequent round of development.
Further, 2- and 4-cell-stage blastomeres are clearly distinguish-
able on the basis of the chromatinmodifiers analyzed (Figure 1B),
which may indicate that each stage has a distinct epigenetic
status. Strikingly, 8-cell blastomeres are more similar to TE cells
than to blastomeres at the nearest developmental time point,
based on chromatin modifier expression (Figure 1B).
The PCA enables us to identify genes that are enriched at
earlier stages of development, namely, Suv39h2, Prmt2, and
Kdm6b (Jmjd3). For example, we find that Prmt2 is a maternal
transcript that is highly expressed in the oocyte and downregu-
lated at fertilization up to the 16-cell stage. Zygotic expression of
Prmt2 presumably commences only at the blastocyst stage
(Figure 1D). Importantly, this pattern of expression of Prmt2 is
recapitulated by the protein (Figure 1E). The mutually exclusive
maternal expression of Suv39h2 and zygotic expression of
Suv39h1 (Figures 1C, 1F, and 1G) is consistent with previous
findings (Puschendorf et al., 2008). Prdm14, Kdm4c (Jmjd2c),
Kdm5b (Jarid1b), and Suv39h1 are genes with very low/absent
transcripts in the oocyte and zygote, and their activation may
therefore mark a developmental transition toward an embryonic
chromatin configuration, concomitant with genome reprogram-
ming (Figure 1A). Kdm5a (Jarid1a) appears as a strong contrib-
utor in demarcating the 8-cell stage (Figure 1C) and Dnmt1 is
on the extreme right-hand side of the PC1 component, suggest-
ing that zygotic Dnmt1 accumulation occurs at later stages of
preimplantation development. This is in line with the known
increase in zygotic Dnmt1 levels toward the blastocyst stage
(Hirasawa et al., 2008).
Thus, early developmental transitions are marked by a distinc-
tive pattern of epigenetic components, with the 8-cell stage
marking the strongest transition in cellular states.
Earlier Developmental States Are More Clearly
Demarcated by Chromatin Modifiers than Later States
To mathematically establish a time sequence in the develop-
ment of individual cells, as well as the characteristics of theirll Reports 5, 687–701, November 14, 2013 ª2013 The Authors 689
(legend on next page)
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Figure 2. Epigenetic Landscape of Preimplantation Development Based on the Expression Profiles of Chromatin Modifiers
A semiquantitative epigenetic landscape was computed from themean values (centers of gravity) and SDs (spread) of the individual cells for each developmental
stage in the PCA in Figure 1B. The two panels represent top-down and side-on perspectives of the same landscape. The x and y axes correspond to the original
PC1 and PC2 axes in the PCA of Figure 1B scaled by a factor of 0.01. The z axis refers to an energy value. The position (well) of each stage is indicated. The
contours in the x and y axes represent the relative height of the landscape in the z axis (contour plots). From the 8-cell stage onward, the points in the PCA plane
are grouped in a single cluster. Note that the distinction of the basins corresponding to stages later than 8-cell and to the ICM and TE on the epigenetic landscape
is weaker compared with the much better defined cellular states for the stages between the oocyte and the 4-cell stage.
See also Figures S1, S4, and Table S1.differentiation paths, we generated an epigenetic landscape
based on the PCA in Figure 1B. For this purpose, we computed
the center of gravity of each cluster of points (individual cells) in
the PCA according to their position on the PCA plane (Figure S4).
This mathematical analysis can be used to generate a proba-
bilistic epigenetic landscape in analogy to the Waddington
landscape (Bhattacharya et al., 2011. The computed, semiquan-
titative epigenetic landscape (Figure 2) has valleys (‘‘creodes’’
according to Waddington’s terminology) and some ridges. The
valleys constitute stable steady states and the ridges can be in-
terpreted as barriers to transitions between those cellular states.
The landscape we generated from the PCA data reveals that
there are only five clearly defined valleys, which correspond
(from left to right) to oocyte, zygote (E1), 2-cell (E2), 4-cell (E4),
and all 8-cell-blastocyst (E8–E32) stages together. It is clear
and reasonable to assume that cells start near the oocyte
‘‘OO’’ valley and that the most likely transition to another well-
defined differentiation state will correspond to the nearest pointFigure 1. Developmental Transitions Are Defined by Distinctive Comb
(A) Hierarchical clustering of single cells derived from embryos at all stages, from
with combined hierarchical clustering of chromatin modifiers. Each stage is color
are labeled with a letter (e.g., E8a) and individual blastomeres from each embryo
blastocyst were preidentified by labeling with a membrane dye. I, inner; O, outer
(B) Principal component (PC) projection of individual cells based on the expressio
stage as above. The first component represents the developmental transition from
ICM-to-TE lineage segregation on the y axis.
(C) PC projections of the 35 genes, showing the contribution of each gene to the fir
more enriched in cells with more positive PC2 scores in Figure 1B.
(D) Absolute unnormalized expression levels of Prmt2 across preimplantation dev
the black bar indicates the median values, and the whiskers indicate the maxim
as dots.
(E) Expression of PRMT2 protein by immunofluorescence. Shown are maximum
(F and G) Absolute unnormalized expression levels of Suv39h1 and Suv39h2 as
See also Figures S1–S3 and Table S1.
Ce(in this case, the zygote [E1]) and subsequently to the 2-cell stage
(E2). Likewise, from the 2-cell stage, themost probable transition
is the 4-cell stage. In other words, a zygote will not develop into a
4-cell-stage ‘‘chromatin landscape,’’ but will first transit through
the 2-cell stage. However, there is no obvious transition from the
4-cell stage onward, as it is not clear which point is closest, and
therefore this might reflect the fact that transitions from the 4-cell
stage are not so well defined by the chromatin factors. In fact, we
can observe that a definite proportion of the analyzed cells end
up in distinct ‘‘differentiation’’ fates. Moreover, although the
wells corresponding to oocyte, zygote, 2-cell, and 4-cell stages
are well defined, those corresponding to the rest of the stages
seem to merge into one larger well. The landscape also has a
general downward trend from left to right (early to later), suggest-
ing a directionality and that the ‘‘ball cannot go back,’’ to use
Waddington’s analogy. This is particularly interesting because
the transitions are consistent with the known time sequence of
events (developmental progression).inatorial Profiles of Epigenetic Modifiers
oocyte to blastocyst, based on the expression levels of 35 chromatin modifiers
ed according to the scheme above throughout the figures. Individual embryos
are labeled with a number (e.g., E8a1-8). TE and ICM cells of the 32-cell-stage
.
n profiles of chromatin modifiers. The cells are colored according to embryonic
oocyte to the 8-cell stage on the x axis, and the second component represents
st two PCs in Figure 1B. For example, a genewith amore positive PC2 loading is
elopment. The boxed region represents the middle 50% of expression values,
um and minimum values. Cells with outlying expression values are depicted
intensity projections of representative embryos. Scale bar is 20 mm.
in Figure 1D.
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Figure 3. Late Developmental Transitions
and Blastocyst Lineages Are Defined Better
by TFs than by Chromatin Modifiers
(A) PC projections of 64-cell-stage blastocyst
single blastomeres based on the expression levels
of 37 chromatin modifiers and nine control genes.
Each dot represents a single cell.
(B) Projections of the genes, showing the contri-
bution of each gene to the first two PCs in (A). Note
that the reference genes make each of the three
clusters on the left panel identifiable as TE(Id2,
Cdx2), EPI (Sox2, Fgf4), and PE (Gata4, PdgfrA).
(C) PC projection of individual cells of 64-cell-
stage embryos based on the expression profiles of
the 37 chromatin modifiers analyzed in (A). Note
that the different lineages are no longer distin-
guishable in the absence of reference TF and
signaling genes.
See also Figure S1and Tables S1 and S2.The temporal sequence in this model originates from the dif-
ferences in the expression of chromatin modifiers and shows
that the earliest stages are better defined than the later stages
based on their chromatin constituents. This finding contrasts
with results obtained from single-cell expression data for TFs
and signaling proteins, which show that there are no significant
variations between single cells prior to compaction, and instead
define clear developmental transitions and lineage segregation
at later stages of development (Guo et al., 2010). To address
this distinction in more detail, we generated single-cell expres-
sion data from 64-cell-stage embryos to profile 37 chromatin
modifiers and nine control and reference genes (Pou5f, Nanog,
Sox2, Fgf4, Pdgfra, Gata4, Cdx2, Id2, and Actin-B; Table S2).
Because we included these relevant marker genes of the three
lineages of the late blastocyst (EPI, PE, and TE) in this analysis,
and the number of genes that one can analyze in the Biomark
is limited, the list of genes analyzed in this experiment is not iden-
tical to that shown in Figure 1 (Table S2). Nevertheless, PCA with
37 chromatin modifiers and nine reference genes shows that
three lineages can be clearly distinguished in 64-cell-stage
embryos, with three clusters of groups of cells (Figure 3A). These
clusters correspond to the three lineages of the 64-cell-stage
blastocyst (the EPI, PE, and TE), as can be appreciated from
the loading position of the respective marker genes on the
PCA (Cdx2 and Id2 for the TE, Gata4 and PdgfrA for the PE,
and Fgf4 and Sox2 for the EPI; Figure 3B). In contrast, when
we performed the PCA with only the 37 chromatin modifiers,692 Cell Reports 5, 687–701, November 14, 2013 ª2013 The Authorswe observed no clear resolution of line-
ages, and instead the same cells were
distributed in a scatter along the principal
components (Figure 3C). Thus, our data
indicate that the three lineages of the
64-cell-stage embryo cannot be distin-
guished on the basis of the chromatin
modifiers they express. This lends sup-
port to our hypothesis that chromatin
modifiers define early developmental
transitions better than at later stages,when lineages can be resolved based on the expression of spe-
cific transcription and signaling factors.
Nonbiased Analysis of Epigenetic Modifiers Delineates
Cellular Differentiation States
We next addressed in detail the unexpected similarity between
the 8-cell-stage and TE cells of the blastocyst with regard to
the expression profiles of their chromatin modifiers. Importantly,
this similarity is lost if TFs are included in the data set (data not
shown), demonstrating that the similarity between these two
cell types is reflected more by chromatin modifiers than TFs,
most likely due to the dramatic upregulation of Cdx2 and Id2 in
the TE. First, we analyzed further the potential similarity between
the 8-cell-stage and TE cells by performing a PCA of just the later
stages of development (4-cell to 32-cell stages; Figure 4A). We
found that the 8-cell-stage blastomeres reproducibly segregate
together with the TE cells. Second, to identify the chromatin
modifiers that are more strongly expressed in these two stages,
as opposed to the ICM cells, we analyzed the raw expression
data. This revealed three genes with similar expression in
8-cell blastomeres and TE cells, but not in ICM cells (Table
S3). These included the H3K4me2/3 demethylase Kdm5a/
Jarid1a, the H3K27me2/3 demethylase Kdm6a/Utx, andDnmt3l,
which were all similarly more strongly expressed in 8-cell-stage
and TE cells compared with ICM cells (Figure 4B). We validated
this enrichment pattern for one of these three proteins, KDM5A/
JARID1A. Indeed, the nuclear accumulation of KDM5A/JARID1A
Figure 4. Similarity between 8-Cell-Stage and TE Cells, Defined by Three Chromatin Modifiers
(A) PC projections of 4-cell-stage to blastocyst single blastomeres based on the expression levels of 35 chromatin modifiers. Each dot represents a single cell.
Colored rings indicate the relative positions of the 8-cell-stage and TE cells in blue and purple, respectively.
(B) Relative expression levels of the indicated genes in 8-cell-stage, ICM, and TE cells. *p < 0.01, **p < 0.001, ***p < 0.0001 (Mann-Whitney test).
(C) Analysis of KDM5A protein in 8-cell-stage cells and blastocysts by immunofluorescence. A single section merge of representative 8-cell stage, TE, and ICM
nuclei is shown on the right. Scale bar is 20 mm.
(D) PC projections of 4-cell-stage to blastocyst single cells based on the expression levels of chromatin modifiers except for Kdm5a, Kdm6a, and Dnmt3l. The
relative positions of 8-cell-stage and TE cells are indicated by blue and purple circles, respectively. Note that the 8-cell-stage cells and TE cells are now well
separated.
See also Figure S1 and Tables S1 and S3.
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was lower in the ICM than in the TE and 8-cell-stage blastomeres
(Figure 4C). Importantly, when we removed these three genes
from the data set before repeating the same PCA as shown in
Figure 4A, we observed that the 8-cell-stage and TE cells failed
to cluster together, indicating that the expression profiles of
these three genes define the similarity between these stages
(Figure 4D).
During both of these stages of development, these two
types of cells uniquely undergo a differentiative transition.
At the 8-cell stage, the first overt changes occur in the
embryo as the individual cells develop polarity, enabling
subsequent differentiative cell divisions (Ziomek and Johnson,
1980). Similarly, TE cells of the blastocyst are also in the
process of differentiating, accompanied by polarization and
epithelization (Rossant and Tam, 2009). Therefore, we hy-
pothesize that the similar pattern of expression of chromatin
modifiers in these two cell types might result in a similar
chromatin architecture that could be permissive for dif-
ferentiation. Our data suggest that JARID1A, UTX, and
DNMT3L may play important roles in setting up a chromatin
configuration necessary for establishing and/or maintaining
the processes of polarization that occur during these two
stages of development.
The Two Lineages of the Blastocyst Can Be Segregated
According to Distinct Profiles of Chromatin Modifiers
The blastocyst is composed of two lineages with very different
states of potency: the TE, which is the first differentiated tissue
in the embryo and therefore has a limited capacity to further
differentiate, and the ICM, which is pluripotent and the origin of
embryonic stem cells (ESCs). We thus asked whether these
two distinct cell types are defined by different combinations of
chromatin modifiers. We analyzed these two lineages in isola-
tion. First, we performed PCA and unsupervised hierarchical
clustering of the individual blastomeres derived from TE or ICM
lineages with the chromatin modifiers and the TF data (Figures
5A and S5A). This analysis resulted in segregation into two
well-defined groups containing either ICM (E32I) or TE (E32O)
cells (p < 0.002; Figures 5A and S5A). The TFs Cdx2 and Id2
clustered together, with higher expression in the TE cells as
expected (Figure S5A). The TF factors characteristic of the ICM
Oct4 and Nanog were not so obviously enriched in the ICM cells
at this stage (Figures 5B and 5C). This could reflect the greater
heterogeneity in the ICM cells, which do not cluster as well as
the TE cells, supporting the view that the TE cells are defined
earlier than the ICM and that the markers for the ICM are not
completely segregated until one or two cycles later (Dietrich
and Hiiragi, 2007).
To determine whether ICM and TE cells can be identified
based on the repertoire of chromatin modifiers they express,
we performed an analysis of all blastocyst cells, but in the
absence of the TF data set. Importantly, this also resulted in
the segregation of ICM and TE (p < 0.025; Figures 5D and
S5B). This reveals that ICM and TE cells at this stage of develop-
ment possess mostly distinct expression patterns of chromatin
modifiers. The ICM versus TE segregation is still the most signif-
icant distinction within the data set in the first principal compo-
nent, although the proportion of the variance in the data set694 Cell Reports 5, 687–701, November 14, 2013 ª2013 The Authorsexplained by this component is significantly higher in the pres-
ence of the TFs (Figure 5A).
We next sought to identify chromatin modifiers that would
impose a signature on either lineage. Figure 5E reveals the
chromatin modifiers that make the greatest contribution to the
segregation of ICM versus TE. Notably, Prdm14 is the most
enriched gene in ICM cells. Conversely, Dnmt3l and Dnmt3b
are the most enriched chromatin modifiers in TE cells and, to a
lesser extent, the H3K9 methyltransferase Suv39h2 (Figure 5E).
Ordering individual cells according to their first PC score (Fig-
ure 5F), and plotting the expression levels of the selected
genes accordingly, further revealed very similar behavior of
Dnmt3b and Dnmt3l, with high expression in TE cells gradually
decreasing to lower levels in ICM cells (Figure 5F). Prdm14, on
the other hand, is only expressed in two cells of the TE, and
then at low levels, whereas its expression is higher but heteroge-
neous in ICM cells (Figure 5F). We validated the Prdm14 and
Dnmt3l patterns of expression in the blastocyst stage by an inde-
pendent approach using single-cell qRT-PCR without preampli-
fication (Figure S5C). Importantly, a previous reporter construct
showed enriched expression of Prdm14 in the ICM (Yamaji
et al., 2008), and we confirmed the mRNA pattern of DNMT3B
at the protein level, which appears largely enriched in the TE (Fig-
ure 5G; see also Hirasawa and Sasaki, 2009). To identify whether
these chromatin modifiers show differential expression levels
across individual cells of the 32-cell-stage blastocyst, we gener-
ated violin plots (Figure S5D). The TE markers show a clear
bimodal expression, reflecting strong expression levels in
some cells (TE cells) and very low or no expression in other cells
(ICM cells). The ICM markers, however, do not show a bimodal
distribution, supporting earlier observations (Dietrich and Hiiragi,
2007; Figure 5C). Notably, Prdm14 adopts themost extreme dis-
tribution of the genes analyzed, farther to the right thanNanog or
Oct4 in the PCA shown in Figure 5B. In line with this, Prdm14
shows a bimodal expression (Figure S5D; data not shown),
whereas Dnmt3b and Dnmt3l exhibit a more graded expression
pattern, fitting with their profiles in Figure 5F.
Thus, the two lineages of the blastocyst can be identified by
the combination of chromatin modifiers that they express, and
the ICM cells show greater heterogeneity in this respect. In
particular, Dnmt3b and Dnmt3l are enriched in TE cells, whereas
Prdm14 is highly enriched in a subpopulation of the ICM.
PRDM14 Is Asymmetrically Distributed in 4-Cell-Stage
Blastomeres
In light of the importance of uncovering the molecular mecha-
nisms that regulate the formation of pluripotent cells, we next
wondered whether we could identify chromatin modifiers that
might play an early, instructive role in ICM cell-fate allocation.
Our observation that Prdm14 is more enriched in ICM cells
than Nanog and Oct4 (Figure 5B) prompted us to ask whether
PRDM14 could play a role in lineage allocation at an earlier stage.
PRDM14 is a PR-domain and zinc finger (ZF) protein whose
expression is restricted to early embryonic tissues during
periods of cellular reprogramming and is required for establish-
ment of germ cells and maintenance of the ESC ground state
(Gillich et al., 2012; Ma et al., 2011; Yamaji et al., 2008, 2013).
PRDM14 is a sequence-specific regulator of gene expression
Figure 5. The Two Lineages of the Blastocyst Can Be Segregated According to the Distinct Profiles of Chromatin Modifiers
(A) PCprojectionof individual cells fromearly blastocystsbasedon theexpressionof chromatinmodifiers andTFs. Thecalculatedprobability of equality between ICM
(E32I) and TE (E32O) is indicated (Kolmogorov-Smirnov test). The orange and purple circles visually indicate the relative positions of ICM and TE cells, respectively.
(B) PC projections of the 39 genes (chromatin modifiers and TFs), showing the contribution of each gene to the first two PCs in (A). The ICM and TE TF ‘‘markers’’
are on the extremes of the PC1, enriched with the positions of the ICM and TE cells in (A), strongly suggesting that this most significant component distinguishes
ICM from TE cells.
(C) Expression profiles of TFs characteristic of the ICM and TE across the population of single cells in the blastocyst. Blastomeres were ordered along the x axis
according to the PC1 score in (A). The traces represent the average normalized expression value of each in gene in moving windows of seven cells. The colored
bars labeled ‘‘Outer’’ and ‘‘Inner’’ represent the mean expression levels at the blastocyst stage for TE and ICM, respectively.
(D) PC projection of individual cells from early blastocysts based on the expression of chromatin modifiers alone, showing a clear segregation of ICM and TE cells
in the PC1. The calculated probability of equality between ICM and TE groups is indicated (Kolmogorov-Smirnov test). The orange and purple circles visually
indicate the relative positions of ICM and TE cells, respectively.
(E) PC projections of the 35 chromatin modifier genes, showing the contribution of each gene to the PCA in (D).
(F) Expression profile of Prdm14, Dnmt3b, and Dnmt3l in the blastocyst across the population of single blastomeres. Blastomeres were ordered along the x axis
according to the PC1 score in (D). The traces represent the average normalized expression value of each gene in moving windows of seven cells.
(G) Immunostaining of DNMT3B at the early blastocyst stage confirms enrichment in TE relative to ICM. Maximal Z projection and a single confocal section for a
representative blastocyst are shown. The position of the ICM is depicted by a dotted line. Scale bar is 20 mm.
See also Figures S1, S5 and Table S1.
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Figure 6. PRDM14 Expression Is Heterogeneous at the 4-Cell Stage
(A) Average expression levels of Prdm14 normalized to control genes between the zygote and the 8-cell stage.
(B) Expression levels ofPrdm14,Dnmt3b, andDnmt3l across the 4-cell population. Single cells were ordered along the x axis based on the PC1 scores of a PCA of
4-cell-stage cells. The average normalized expression value of each gene in moving windows of four cells was then plotted (as for Figure 5C). A gradient of
Prdm14 expression is observed that inversely correlates with expression ofDnmt3b and, to a lesser extent,Dnmt3l. The colored bars labeled ‘‘Outer’’ and ‘‘Inner’’
represent the mean expression levels at the blastocyst stage for TE and ICM, respectively.
(C) Bars represent the absolute, unnormalized Prdm14 expression level in each cell of three 2-cell (green) and three 4-cell (blue) stage embryos.
(D) Immunofluorescence of PRDM14 in late 2-cell and early and late 4-cell-stage embryos. Shown are maximum intensity projections of representative embryos.
Scale bar is 20 mm.
(E) Quantification of PRDM14 in early and late 4-cell-stage embryos. The fluorescence intensity per nucleus was normalized to the nucleus with the strongest
staining per individual 4-cell-stage embryo, and the mean averages of these ratios are shown (± SEM). The Mann-Whitney U test was applied.
See also Figures S1 and S6, Table S1.that plays both activating and repressive roles in transcription
depending on the chromosomal context. Interestingly, we find
that, unlike the lineage-specific TFs, which function in lineage
allocation at later stages, Prdm14 is strongly expressed at the
2-cell stage; its expression is downregulated and becomes
highly variable at the 4- and 8-cell stages, and is subsequently
lost by the 16-cell stage (Figure 6A). Ordering of 4-cell-stage
blastomeres according to the first principal component scores
of the PCA based on just the single 4-cell-stage blastomeres
(not shown) reveals a gradient of Prdm14 expression, indicating
that Prdm14 shows strong variations in its expression levels
among individual 4-cell blastomeres (Figure 6B). Interestingly,
we find opposing patterns of expression of Dnmt3b and Dnmt3l
compared with that of Prdm14 at the 4-cell stage (Figure 6B),696 Cell Reports 5, 687–701, November 14, 2013 ª2013 The Authorssimilarly to the inverse correlation found in the blastocyst.
Expression of Prdm14 at the 4-cell stage is weakly correlated
with Oct4 (R = 0.56) and Nanog (R = 0.42), whereas the outer
markers are very weakly or not expressed at this stage. Impor-
tantly, analysis of single cells from individual embryos revealed
that heterogeneous Prdm14 expression emerges at the 4-cell
stage and is strikingly intraembryonic, with two blastomeres of
each 4-cell-stage embryo expressing Prdm14 and the other
two showing no or very low Prdm14 expression (Figure 6C).
We next addressed whether the asymmetric distribution of
Prdm14 mRNA levels translates into changes in accumulation
of the protein between blastomeres. Remarkably, we find that
although 2-cell-stage and early 4-cell-stage blastomeres display
equivalent levels of PRDM14 protein, late 4-cell-stage embryos
display an asymmetric distribution of PRDM14, with two cells
displaying strong nuclear accumulation of PRDM14 and two
cells showing low levels, in agreement with the mRNA pattern
(Figures 6D and 6E). Thus, PRDM14 is heterogeneously distrib-
uted in late 4-cell embryos, suggesting that epigenetic differ-
ences develop by the end of the 4-cell stage.
PRDM14PromotesH3R26Methylation andDirects Cells
toward the Pluripotent ICM
Given the opposing patterns of expression of Prdm14 versus
Dnmt3b/3l in the blastocyst, the high enrichment of Prdm14 in
the ICM, and the remarkable asymmetry of its accumulation at
the 4-cell stage, we hypothesized that PRDM14 may play a
role in lineage allocation, with cells expressing higher levels of
Prdm14 being more likely to generate ICM cells. To test this
hypothesis directly, we overexpressed PRDM14 by injecting its
mRNA in combination with that of GFP as lineage tracer into
one cell of a late 2-cell-stage embryo and monitored develop-
ment to the blastocyst (Figure 7A). We verified that injection of
mRNA for PRDM14 resulted in elevated levels of the protein at
the 4-cell stage (Figures 7B and S6A). Embryos overexpressing
Prdm14 developed normally and reached the blastocyst stage
in ratios similar to those observed for embryos injected with
mRNA for GFP only (summary: Table S4; raw data: Tables S5
and S6). We reconstructed the resulting blastocysts in three
dimensions as described previously (Torres-Padilla et al., 2007)
using cortical F-actin staining to locate every inner (ICM) and
outer (TE) cell in the blastocyst to determine which lineage the
labeled cells had contributed to (Table S4; Movies S1 and S2).
The blastocyst at this stage is composed mostly of TE cells
(approximately two-thirds of the total cells are TE cells). In con-
trol embryos, therefore, the expected random contribution to
the ICM of a 2-cell blastomere progeny is one-third, which accu-
rately corresponds to the one we obtained upon injection of GFP
only (30.97% ± 7.38%; Tables S4 and S5; Movie S1). In contrast,
we consistently observed a higher than expected contribution to
the ICM of the progeny of the Prdm14-injected cell (p = 0.0058;
Figure 7C). The proportion of the Prdm14-clone allocated to the
ICMwas 1.37-fold higher than that of the controlGfp-clone: 41%
for Prdm14 versus 30% for a random, GFP distribution (Tables
S4–S6; Movies S2 and S2). Representative control and
Prdm14-injected blastocysts are shown in Figure 7D.
In order to dissect the requirement of the functional domains
within PRDM14 for cell-fate induction, we generated three
different constructs: (1) PRDM14 lacking the ZF and therefore
unable to bind to DNA (Ma et al., 2011), (2) PRDM14 lacking
the PR domain, and (3) PRDM14 lacking the N terminus and con-
taining only the PR and ZF domains (Figure 7E). The PR-ZF-only
PRDM14 construct did not localize in the nucleus and instead
resulted in cytoplasmic accumulation of PRDM14, precluding
further analysis (data not shown). Importantly, expression of
the PRDM14DZF construct did not cause an effect on cell
fate, suggesting that DNA binding is required for induction of
ICM cell fate (Figure 7C; Tables S4 and S7). Expression of
PRDM14DPR in individual 2-cell blastomeres resulted in two
distinct phenotypes. A large majority of the embryos (78%;
n = 22) developed abnormally. Either these embryos did not
generate a correct number of cells in the blastocyst or the contri-Cebution of the Prdm14DPR-injected cells to the total number of
cells was less than 50%, suggesting a potential dominant-nega-
tive effect with a deleterious impact on development or cell
division. In the remaining 22% of the embryos that reached the
blastocyst stage, expression of PRDM14DPR did not result in
a consistent effect on cell-fate allocation (Table S8). Thus, we
conclude that overexpression of Prdm14 in a 2-cell blastomere
leads to a biased contribution of that cell to the ICM in the blas-
tocyst, and that both the ZF and the PR domain of PRDM14 are
required for this effect.
The only other protein known to date to affect cell-fate alloca-
tion during preimplantation development is CARM1/PRMT4,
whose overexpression also directs cells toward the ICM
(Torres-Padilla et al., 2007). Therefore, we next asked whether
PRDM14 and CARM1 might function in the same pathway.
Unfortunately, we had to omit Carm1 from our Fluidigm analyses
because the Taqman assays available did not produce a reliable
quality control. To determine whether PRDM14 and CARM1
function in parallel, we first examined whether PRDM14 affects
global levels of H3R26 methylation, a substrate of CARM1
(Chen et al., 1999). Expression of Prdm14 in one 2-cell blasto-
mere led to a significant 1.5-fold increase in global H3R26me2
levels compared with noninjected or GFP-only-injected controls
(Figures 7F and S7), similar to Carm1 overexpression (Torres-
Padilla et al., 2007). In line with the cell-fate effects described
above, neither the PRDM14DZF nor the PRDM14DPR con-
structs affected H326me2 levels (Figures 7F and S7). Second,
we asked whether PRDM14 and CARM1 physically interact,
which would provide a mechanistic basis for PRDM14 and
CARM1’s function in cell-fate allocation. We performed coimmu-
noprecipitation analyses in ESCs because they express both
proteins endogenously (Figure 7G), and because we cannot
perform immunoprecipitation in embryos due to the limited
amount of material they can provide. We used 3T3 fibroblasts
as a negative control because they do not express PRDM14 (Fig-
ure 7G; Yamaji et al., 2008). We find that endogenous CARM1
coimmunoprecipitates with PRDM14, suggesting that both pro-
teins act together on some of their targets to regulate chromatin
function.
DISCUSSION
The period of preimplantation development results in the gener-
ation of a differentiated blastocyst capable of implantation. This
differentiation is accompanied by a transition from totipotency to
the allocation of two distinct lineages with two distinct cellular
potency states: pluripotent and differentiated. Our study pro-
vides insights into the quantitative and combinatorial expression
patterns of 35 key chromatin-modifying enzymes during these
dynamic shifts in the cellular state, at single-cell resolution.
Approaches that address single-cell dynamics are becoming
crucial to understand both the significance of biological hetero-
geneity and the molecular changes that occur upon defined
cell-fate transitions. This will be essential for elucidating complex
biological processes and obtaining single-cell measurements
with high temporal and spatial resolution. This in turn will allow
the generation of kinetic models that can be used to predict reg-
ulators and their mode of action. Earlier microarray studies withll Reports 5, 687–701, November 14, 2013 ª2013 The Authors 697
Figure 7. PRDM14 Directs Cells toward the ICM from the 4-Cell Stage
(A) Outline of the experimental design. A single 2-cell blastomere wasmicroinjected withHA-Prdm14 and gfp or gfpmRNA alone. Embryos were cultured until the
blastocyst stage and then fixed. The GFP-positive progeny of the injected cell were then positioned as inner or outer cells by 3D digital image reconstruction.
(B) Embryos injected as above and stained with HA antibody. Shown is a maximum intensity projection of a representative embryo. Scale bar is 20 mm.
(C) Prdm14 expression biases cells toward an ICM fate. The proportion of the progeny of the PRDM14-injected and PRDM14DZF-injected cells allocated to the
ICM is shown relative to the GFP controls, which was set at one and corresponds to the expected random contribution (the raw data are shown in Tables S4–S7).
(D) Representative blastocysts from the PRDM14- and GFP-injected groups. The position of the cavity is indicated with a dashed line. Scale bar is 20 mm.
(E) Schematic of PRDM14 and the deletion constructs used, indicating the PR domain (aa 241–362) and the C-terminal domain containing six ZFs (aa 390–561).
(F) PRDM14 microinjection leads to increased H3R26me2 levels. Embryos were injected as in (A), fixed 24 hr later, and stained with an H3R26me2 antibody.
Shown is a maximum intensity projection of a representative embryo. Scale bar is 10 mm. The graph shows the average of the ratio of fluorescence intensity
(± SEM) of the H3R26me2 signal per nucleus in GFP-only and PRDM14-, PRDM14DZF-, and PRDM14DPR-injected progeny nuclei compared with noninjected
progeny nuclei per embryo. The Mann-Whitney U test was applied.
(G) PRDM14 interacts with CARM1 in ESCs.Mouse ESCs or 3T3 cells were subjected to immunoprecipitationwith a PRDM14 antibody. Membraneswere probed
with a CARM1 or PRDM14 antibody as control.
(H) Working model depicting the proposed mechanism for the cooperative role played by PRDM14 and CARM1 in biasing cell fate toward the ICM lineage.
PRDM14 associates with CARM1 and targets this histonemethyltransferase to chromatin via the ZF DNA-binding domain of PRDM14. At the late 4-cell stage, the
two cells that express higher levels of PRDM14 thus have more chromatin-associated CARM1, resulting in globally higher levels of histone arginine methylation
(e.g., H3R26me2), which in turn leads to transcriptional activation of the genetic program for establishing the ICM lineage.
See also Figures S1, S6, and S7, and Tables S1 and S4–S8, and Movies S1 and S2.
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whole embryos or RNA sequencing in single cells (Hamatani
et al., 2004; Wang et al., 2004; Tang et al., 2011) shed light on
the global changes that accompany developmental progression.
In contrast to our analysis, which used total RNA, those studies
were performed using polyadenylated mRNA. We used total
RNA because of the known regulation of mRNA translation in
the embryo due to the absence of polyA or the use of alternative
polyA lengths, and therefore this should be taken into account for
future and comparative analyses. Moreover, the use of microflui-
dics technology combined with gene-specific Taqman assays
reduces the amplification bias, which represents a major advan-
tage when addressing quantitative parameters in single cells
(Guo et al., 2010; Lorthongpanich et al., 2012).
The computed epigenetic landscape we generated highlights
that the expression patterns in the oocyte, zygote, and 2- and
4-cell-stage cells are more different from each other than those
observed in later stages, and that the most dramatic changes
in expression of chromatin modifiers take place at earlier stages.
This could imply that the most dramatic ‘‘epigenetic reprogram-
ming’’ occurs earlier. Later on, there are more subtle differences,
suggesting that only a few chromatin modifiers define later
transitions (e.g., PRDM14/DNMT3L for ICM versus TE cells).
Alternatively, it could be that at later stages of development,
the ‘‘control’’ of cell fate is no longer epigenetic, but rather
occurs via TFs, raising the possibility that the chromatin first
sets up an environment for cell-fate ‘‘choices’’ and subsequently
the TFs consolidate those choices. It should be noted that
although most chromatin modifiers do not show a preimplanta-
tion phenotype when knocked out, the function of these genes
during early development has not been examined because
many of them are inherited maternally. Indeed, in the few cases
in which chromatin modifiers were deleted in the maternal
germline, such as for Ezh2 and Brg1, an early preimplantation
phenotype was observed (Bultman et al., 2006; Erhardt et al.,
2003). Our study highlights the need to perform maternal
knockout studies on specific chromatin modifiers to determine
whether they may play a role in reprogramming.
Based on the signature of chromatin modifiers, individual cells
segregate into their embryonic stage rather than individual
embryos. This suggests that significant transitions occur in the
composition of chromatin modifiers between stages over the
course of preimplantation development, which is likely to be
reflected by a dynamically evolving chromatin architecture dur-
ing this period. We therefore hypothesize that chromatin-based
changes that accompany the transitions in potency and lineage
allocation are functionally important for these processes.
Indeed, we validated this hypothesis by demonstrating a role
for PRDM14 in inducing lineage allocation from the 4-cell stage.
The PRDM family of proteins is best characterized by PRDM1/
BLIMP1, a sequence-specific regulator that is required for
germ cell specification (Ohinata et al., 2005). Interestingly and
uniquely, to our knowledge, PRDM14 is specifically expressed
in defined windows during development (2- to 8-cell-stage
embryos [this work], the epiblast, and primordial germ cells
[Yamaji et al., 2008]), corresponding to critical periods of shifts
in cellular potency and reprogramming. PRDM14 has been
shown to function in repression as well as in activation of cell-
specification genes and epigenetic regulators (Gillich et al.,Ce2012; Ma et al., 2011; Yamaji et al., 2013). In ESCs, PRDM14 re-
presses Dnmt3b and Dnmt3l, genes that show an inverse corre-
lation to Prdm14 expression in both 4-cell-stage embryos and
blastocysts. Thus, it is likely that PRDM14 plays a role in repres-
sing Dnmt3b/3l in the embryo.
The interaction with CARM1 that we uncovered, together
with our observations that PRDM14 promotes global levels of
H3R26me2 (an active chromatin mark) in the embryo, suggests
that PRDM14 promotes ICM fate and pluripotency in vivo at
least partially through the generation of a more open chromatin
configuration, which is more typical of pluripotent cells
(Meshorer et al., 2006). It is conceivable that at the 4-cell-stage,
PRDM14, through its ZF domain, guides CARM1, which is ex-
pressed in a rather homogeneous fashion at this stage (data
not shown; Torres-Padilla et al., 2007), to its target genes (Fig-
ure 7H). Thus, PRDM14 might promote stem cell fate allocation
to the ICM both by favoring an open chromatin configuration and
by repressing differentiation genes. This model is complemen-
tary to the proposed mechanism of action for promoting
ground-state pluripotency by PRDM14 in ESCs in vitro through
PRC2-mediated repression (Yamaji et al., 2013), which may
apply at later stages in vivo, since Ezh2 is weakly expressed
before implantation (Figure S1). Further, we did not detect any
effect of PRDM14 expression on H3K9me2 levels (Figure S7), a
mode of PRDM14 action that was previously described in the
germline (Yamaji et al., 2008; Magnu´sdo´ttir et al., 2013). Like-
wise, PRDM14 dampens fibroblast growth factor receptor
(FGFR) signaling to promote a primed pluripotency state in
cultured ESCs (Yamaji et al., 2013). However, FGFR signaling
is only important for later stages of development upon EPI and
PE lineage restriction from the ICM, and does not affect the initial
specification of the ICM itself (Chazaud et al., 2006; Kang et al.,
2013). Together, these findings suggest that the mechanism of
action of PRDM14 might differ depending on the cell type in
which it is expressed, highlighting the importance of addressing
PRDM14 function in its native context.
Lineage allocation is likely to involve amulticomponent cellular
process, perhaps including stochastic decisions. Therefore,
PRDM14 most probably does not play a master regulator role
in lineage allocation, but rather acts as one component of a
pathway that is involved in specification toward lineages that
give rise to proportionally more ICM than TE cells. Thus, it seems
that the forced expression of Prdm14 does not alter the intrinsic
process of differentiation per se, but biases the cells in which
it is expressed at higher levels to fall into one fate pathway.
The contribution of stochastic changes in gene expression
to patterning of the early embryo (Dietrich and Hiiragi, 2007;
Tabansky et al., 2013) is also compatible with this conclusion.
An important conclusion of our analysis is that the ICM and TE
can be demarcated on the sole basis of the combination of the
chromatin modifiers that they express. This implicates a distinct
chromatin structure in these two lineages (Ahmed et al., 2010;
Alder et al., 2010). The fact that ICM cells do not cluster together
aswell as TE cells indicates that ICMcells showmore variability in
the chromatin modifiers they express. This is consistent with the
suggestion that cells that have not yet undergone a cell-fate deci-
sion (ICMcells) display a higher ‘‘transcriptional noise’’ than those
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Lastly, we find that 8-cell-stage blastomeres are most similar
to TE cells of the blastocyst. This is particularly surprising
because it suggests that 8-cell-stage blastomeres are more
similar to TE cells than to their closest developmental stages in
their epigenetic constituents. In contrast, in a similar analysis
focusing on expression patterns of TFs (Guo et al., 2010), the
8-cell-stage blastomeres clusteredwith the ICM cells of the blas-
tocyst. This implies that the similarity between the 8-cell-stage
and TE cells of the blastocyst stems from the chromatin land-
scape. Indeed, removal of just three genes (Kdm5a, Kdm6a,
and Dnmt3l) from the data set results in a loss of their clustering
in the PCA. Because a differentiation process is initiated in both
of these cell types, it is tempting to speculate that the three
genes identified (Kdm5a, Kdm6a, and Dnmt3l) may play a func-
tional role in initiating differentiation at both of these stages.
Indeed, both Kdm5a (Rbp2) and Kdm6a (Utx) have been shown
to promote differentiation in other systems (Agger et al., 2007;
Lan et al., 2007; Lopez-Bigas et al., 2008), and DNA methylation
is necessary to allow differentiation and contribution to the EPI
lineages (Sakaue et al., 2010).
In summary, we have shown that a quantitative analysis of the
expression of chromatin modifiers in single cells reveals a
pattern of developmental transitions in the embryo and can pre-
dict cellular differentiation states. Importantly, we have identified
PRDM14 as a regulator of cell-fate allocation. We propose that
the combinatorial expression of chromatin modifiers defines
cellular differentiation states and transitions in potency.
EXPERIMENTAL PROCEDURES
Embryo Collection
Embryos were collected from natural matings. Single oocytes, zygotes, or
blastomeres were washed in PBS and flash-frozen in liquid nitrogen in
5 ml 23 reaction buffer.
All animal work was performed in accordance with the current legislation in
France and with the approval of the regional ethics committee (COMETH).
High-Throughput Single-Cell qPCR
TaqMan Gene Expression Assays (Applied Biosystems) were pooled to a final
concentration of 0.23. For detailed reaction conditions, see Supplemental
Experimental Procedures. Cell lysis and sequence-specific reverse transcrip-
tion were performed at 50C, followed by sequence-specific preamplification.
The resulting cDNA was diluted 5-fold and analyzed in 48:48 dynamic arrays
on a Biomark System (Fluidigm).
Raw Data Treatment and Visualization
All raw cycle threshold (Ct) values were normalized to the Ct detection level of
28. Ct values were further normalized by subtracting the respective Actin and
RPLP0 as described by Guo et al. (2010). For visualization purposes, this
normalization was omitted for Figures 1D–1F, 5C, and S1. PCAwas performed
on normalized Ct values using the svd command in R. Hierarchical clustering
was performed using the Euclidean distances, and dendrograms were dis-
played along row-scaled heatmaps using the gplots package.
Single-Cell qPCR Validation
Validation was performed on single cells without preamplification collected in
5 ml 23 reaction buffer as described above on a LightCycler 480 Real-Time
PCR System (Roche).
Embryo Microinjection and Culture
One blastomere of 2-cell-stage embryos was microinjected with capped
hemagglutinin (HA)-tagged PRDM14 mRNA in combination with mRNA for700 Cell Reports 5, 687–701, November 14, 2013 ª2013 The AuthorsGFP. Prdm14DZF comprises 1–1,104 bp of mPrdm14, and Prdm14DPR
corresponds to fragments 1–718 and 1,086–1,686 bp of mPrdm14.
Immunofluorescence and Confocal Analysis of Embryos
Embryos were processed as described previously (Torres-Padilla et al., 2006).
The antibodies used were anti-HA (Roche), anti-H3R26me2 (07-215; Millipore),
anti-Dnmt3b (184A; Imgenex), anti-KDM5A (3876P;Cell Signaling), anti-PRMT2
(ARP40196; Aviva), anti-H3K9me2 (07-441; Millipore), and anti-PRDM14 (Rein-
berg laboratory).
Generation of the Map for an Epigenetic Landscape
In order to construct an epigenetic landscape, we first determined the number
and location of the minima (valleys or wells) and the qualitative features of the
corresponding graph (Bhattacharya et al., 2011). For a thorough explanation,
see Supplemental Experimental Procedures.
Immunoprecipitation
Immunoprecipitation was performed with affinity-purified polyclonal PRDM14
antibody (antibody characterization is shown in Figure S6) and immunoblotting
with anti-Carm1 (09-818; Millipore).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, eight tables, and two movies and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2013.09.044.
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